NBY

#4524
NovaBay Pharmaceuticals, Inc.
1.1950 USD
-5.16%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.1650
1.2100
Range Annuel
0.4673
2.8000
Changement quotidien
-5.16%
Changement Mensuel
+148.91%
Evolution sur 6 mois
+148.91%
Changement Annuel
+148.91%
Clôture Précédente
1.2600
Open
1.1675
Bid
1.1950
Ask
1.1980
Low
1.1650
High
1.2100
Volume
50
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.4044 M
  • Employee 14
  • Founded 2000
  • CEO N/A
  • Website www.novabay.com
  • Headquarter Delaware, United States
  • FIGI BBG000PVPJT3
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.37
Price to sales ratio
0.21

NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis

Nouvelles